en
Scientific article
English

Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients

Published inAntimicrobial agents and chemotherapy, vol. 51, no. 4, p. 1341-1350
Publication date2007
Abstract

Intubated patients frequently become colonized by Pseudomonas aeruginosa, which is subsequently responsible for ventilator-associated pneumonia. This pathogen readily acquires resistance against available antimicrobials. Depending on the resistance mechanism selected for, resistance might either be lost or persist after removal of the selective pressure. We investigated the rapidity of selection, as well as the persistence, of antimicrobial resistance and determined the underlying mechanisms. We selected 109 prospectively collected P. aeruginosa tracheal isolates from two patients based on their prolonged intubation and colonization periods, during which they had received carbapenem, fluoroquinolone (FQ), or combined beta-lactam-aminoglycoside therapies. We determined antimicrobial resistance phenotypes by susceptibility testing and used quantitative real-time PCR to measure the expression of resistance determinants. Within 10 days after the initiation of therapy, all treatment regimens selected resistant isolates. Resistance to beta-lactam and FQ was correlated with ampC and mexC gene expression levels, respectively, whereas imipenem resistance was attributable to decreased oprD expression. Combined beta-lactam-aminoglycoside resistance was associated with the appearance of small-colony variants. Imipenem and FQ resistance persisted for prolonged times once the selecting antimicrobial treatment had been discontinued. In contrast, resistance to beta-lactams disappeared rapidly after removal of the selective pressure, to reappear promptly upon renewed exposure. Our results suggest that resistant P. aeruginosa is selected in less than 10 days independently of the antimicrobial class. Different resistance mechanisms lead to the loss or persistence of resistance after the removal of the selecting agent. Even if resistant isolates are not evident upon culture, they may persist in the lung and can be rapidly reselected.

Keywords
  • Anti-Bacterial Agents/ pharmacology/therapeutic use
  • Bacterial Proteins/genetics/ metabolism
  • Drug Resistance, Bacterial
  • Humans
  • Longitudinal Studies
  • Pneumonia, Ventilator-Associated/ microbiology
  • Polymerase Chain Reaction
  • Pseudomonas Infections/drug therapy
  • Pseudomonas aeruginosa/ drug effects/genetics/isolation & purification
  • Beta-Lactamases/biosynthesis/genetics
Citation (ISO format)
REINHARDT, Anita et al. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients. In: Antimicrobial agents and chemotherapy, 2007, vol. 51, n° 4, p. 1341–1350. doi: 10.1128/AAC.01278-06
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0066-4804
539views
0downloads

Technical informations

Creation06/21/2010 10:26:09 AM
First validation06/21/2010 10:26:09 AM
Update time03/14/2023 3:45:20 PM
Status update03/14/2023 3:45:20 PM
Last indexation05/02/2024 11:37:26 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack